BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1327864)

  • 1. Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
    Bava AJ; Negroni R
    Eur J Epidemiol; 1992 May; 8(3):422-6. PubMed ID: 1327864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of four antifungal drugs in an experimental model of murine cryptococcosis.
    Bava AJ; Iovannitti C; Negroni R
    Mycopathologia; 1989 Nov; 108(2):81-8. PubMed ID: 2594050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flucytosine+fluconazole association in the treatment of a murine experimental model of cryptococcosis.
    Bava AJ; Negroni R
    Rev Inst Med Trop Sao Paulo; 1994; 36(6):551-4. PubMed ID: 7569631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
    Shindo K
    Drugs Exp Clin Res; 1990; 16(7):327-32. PubMed ID: 1965500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
    Silva EG; Paula CR; Dias AL; Chang MR; Ruiz Lda S; Gambale V; Prates RA; Ribeiro MS
    Mycopathologia; 2011 Apr; 171(4):261-6. PubMed ID: 20972836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole and flucytosine+itraconazole combination in the treatment of experimental cryptococcosis in hamsters.
    Iovannitti C; Negroni R; Bava J; Finquelievich J; Kral M
    Mycoses; 1995; 38(11-12):449-52. PubMed ID: 8720194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
    mBio; 2019 May; 10(3):. PubMed ID: 31138748
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cryptococcal meningitis in mice with fluconazole.
    Palou de Fernandez E; Patino MM; Graybill JR; Tarbit MH
    J Antimicrob Chemother; 1986 Aug; 18(2):261-70. PubMed ID: 3019986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of experimental meningeal and disseminated cryptococcosis.
    Van Cutsem J
    Mycoses; 1993; 36(11-12):357-67. PubMed ID: 7935566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for systemic mycosis.
    Polak A
    Infection; 1989; 17(4):203-9. PubMed ID: 2548963
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of disseminated histoplasmosis in hamsters.
    Finquelievich JL; Negroni R; Iovannitti C; Bava AJ
    Mycopathologia; 1989 Feb; 105(2):75-8. PubMed ID: 2546081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Silva EG; Paula CR; de Assis Baroni F; Gambale W
    Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.
    Graybill JR; Williams DM; Van Cutsem E; Drutz DJ
    Rev Infect Dis; 1980; 2(4):551-58. PubMed ID: 6255531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    Perfect JR; Durack DT
    J Infect Dis; 1982 Sep; 146(3):429-35. PubMed ID: 6286799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental cryptococcosis with SCH 39304 and fluconazole.
    Negroni R; Costa MR; Finquelievich JL; Iovannitti C; Agorio I; Tiraboschi IN; Loebenberg D
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1460-3. PubMed ID: 1929309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.